Signal Advisors Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.26M Buy
6,511
+1,502
+30% +$721K 0.16% 111
2026
Q1
$2.46M Buy
5,009
+200
+4% +$109K 0.17% 119
2025
Q4
$2.79M Buy
4,809
+380
+9% +$215K 0.22% 90
2025
Q3
$2.15M Buy
4,429
+2,127
+92% +$990K 0.19% 105
2025
Q2
$933K Buy
2,302
+1,005
+77% +$420K 0.07% 217
2025
Q1
$646K Buy
1,297
+87
+7% +$47.1K 0.06% 239
2024
Q4
$630K Buy
1,210
+187
+18% +$103K 0.07% 234
2024
Q3
$633K Buy
+1,023
New +$606K 0.09% 221

Other funds holding TMO

Signal Advisors Wealth's TMO Position: Q2 2026 in Review

Signal Advisors Wealth increased its Thermo Fisher Scientific (TMO) stake by 30% in Q2 2026, buying an estimated $721K and bringing the position to 6,511 shares worth $3.26M. The position accounts for 0.16% of the portfolio, ranked #111.

Signal Advisors Wealth first reported a position in TMO in Q3 2024 and has held it in 8 quarters since. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Signal Advisors Wealth held 6,511 shares of Thermo Fisher Scientific worth $3.26M as of Q2 2026.
  • Signal Advisors Wealth bought 1,502 Thermo Fisher Scientific shares in Q2 2026, an estimated $721K.
  • Thermo Fisher Scientific made up 0.16% of Signal Advisors Wealth's portfolio in Q2 2026, its #111 holding.
  • Signal Advisors Wealth first reported a position in Thermo Fisher Scientific in Q3 2024 and has held it in 8 quarters since.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Signal Advisors Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.